The rollout of COVID-19 vaccines across the UK has been praised as an "extraordinary feat" by the official inquiry into the pandemic. This fourth report from the inquiry highlights the unprecedented speed at which vaccines were developed and deployed, with 132 million doses administered in 2021. It also commends the UK's success in identifying effective treatments against the virus, such as the widely available steroid dexamethasone, which helped prevent fatal lung damage.
Baroness Hallett, chair of the inquiry, underscored the life-saving impact of the vaccination programme. Research cited in the report suggests that the initiative saved more than 475,000 lives, with over 90% of individuals aged 12 and above receiving a jab. Despite this widespread uptake, the report acknowledges lower vaccination rates within communities in areas of higher deprivation and among some ethnic minority groups. It calls for governments and health services to collaborate with communities to rebuild trust and enhance understanding and confidence in vaccines, particularly in light of falling uptake for routine childhood vaccinations since the pandemic.
A critical aspect of the report addresses the need for significantly improved support for individuals who have been harmed by COVID-19 vaccines. While this group represents a small minority, the inquiry argues that the existing support mechanisms require urgent reform. The Vaccine Damage Payment Scheme, which offers financial assistance from the government, has received over 20,000 COVID-19 related claims. However, only approximately 1% have resulted in the one-off, tax-free award of £120,000. The report states that the current system, requiring individuals to demonstrate at least "60% disability," is not fit for purpose concerning COVID vaccines.
The inquiry recommends that the £120,000 payout, which has remained unchanged since 2007, should be increased at least in line with inflation. Furthermore, it suggests introducing new payment levels based on the severity of the injury suffered. For example, Kerry Clarkson, 49, who experienced a rare blood clot linked to the Oxford AstraZeneca jab and now suffers from chronic health issues, was denied a payout as her condition did not meet the scheme's threshold, highlighting the scheme's limitations.
The report also critiques the government's attempts to mandate COVID-19 vaccination for health and care workers. Initially, care home workers were required to be jabbed by June 2021, with plans to extend this to all health and care staff. However, these mandates were later scrapped amid growing evidence that the vaccine's primary benefit was preventing severe illness rather than stopping infection. The inquiry suggests this approach may have contributed to alienation and increased vaccine hesitancy among some.
The findings offer a nuanced perspective on the UK's pandemic response, celebrating the monumental success of the vaccine rollout while also identifying crucial areas for improvement in public health communication, community engagement, and support for those adversely affected by medical interventions. It underscores the ongoing challenges in maintaining public trust and ensuring equitable access to healthcare interventions.